Improvement of surgical outcomes in patients with prostatic adenoma due to postoperative administration of the drug likoprofit
- Authors: Ergakov DV1, Martov AG1, Maksimov VA1, Ergakov DV1, Martov AG1, Maximov VA1
-
Affiliations:
- Issue: No 1 (2009)
- Pages: 24-28
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/276934
- ID: 276934
Cite item
Full Text
Abstract
We studied efficacy and safety of likoprofit pharmacotherapy in patients early after transurethral resection (TUR) of the prostate. The drug was well tolerated - no withdrawals were noted. Likoprofit showed high efficacy early after TUR for prostatic adenoma in correction of irritative disorders of urination (frequent voiding, urges, painful urination with small urine portions). This means a significant improvement in quality of life in patients after TUR.
References
- Лопаткин Н. А. (ред.). Доброкачественная гиперплазия предстательной железы. М.; 1999. 193-209.
- Мартов А. Г., Лопаткин Н. А. Руководство по трансуретральной эндоскопической хирургии доброкачественной гиперплазии предстательной железы. М.: Триада-Х; 1997.
- Ситдыкова М. Э., Зубков А. Ю. Клиническая эффективность Ликопрофита в лечении хронического простатита. Эффект. фармакотер. в урол. 2006; 2.
- Bruskewitz R. C., Larsen E. H., Madsen P. O., Dorlflinger T. 3-year follow-up of urinary symptoms after transurethral resection of the prostate. J. Urol. (Baltimore) 1986; 136: 613-615.
- Giovannucci E. A review of epidemiologic studies of tomatoes, lycolpene and prostate cancer. Proc. Soc. Exp. Biol. (N. Y.) 2002; 227 (10): 852-859.
- Debruyne F. M., Jardin A., Colloi D. et al. Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. Eur. Urol. 1998; 34: 169-175.
- Donovan J. L., Peters T. J., Neal D. E. et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The ClasP study. J. Urol. (Baltimore) 2000; 164 (1): 65-70.
- Lepor H. For the Tamsulosin Investigator Group: Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Urology 1998; 51: 892-900.
- Speakman M. J. Initial choices and final outcomes in lower urinary tract symptoms. Eur. Urol. 2001; 40 (suppl. 4): 21-30.
- Мартов А. Г., Гущин Б. Л., Ощепков В. Н., Ергаков Д. В. Применение a1-адреноблокаторов для лечения нарушений мочеиспускания у больных после трансуретральной резекции предстательной железы. Урология 2002: 5, прил.: 23-37.
Supplementary files
